Table 4:

Clinical findings at screening for patients who did and did not develop IFRS after transplantation

	All at Pre-HCT Screen	No Post-HCT IFRS	Post-HCT IFRS	P Value
No.	100	98	2
ENT risk estimate (No.) (frequency)
At risk	29 (29%)	28 (29%)	1 (50%)	.61
Low risk	67 (67%)	62 (63%)	1 (50%)
Not evaluated	4 (4%)	8 (8%)	0
ANC at imaging (mean)	2510 ± 5568	2524 ± 5622	1800 ± 1697	.86
Transplant donor (No.) (frequency)
Allogenic	66 (66%)	65 (66%)	1 (50%)	1
Autologous	34 (34%)	33 (34%)	1 (50%)
Disease status at transplantation (No.) (frequency)
Complete remission	82 (82%)	80 (80%)	2 (100%)	1
Active disease	18 (18%)	18 (18%)
T-cell depletion (No.) (frequency)	2 (2%)	2 (2%)	0	1
GVHD II–IV (No.) (frequency)	15 (15%)	15 (15%)	0	1

Note:—ANC indicates absolute neutrophil count.